DR info

Clinical trials : 11 / Drugs : 23 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 35

Drugs and their primary sponsors and trial info

18F-deoxyglucose (FDG)
   Nantes University Hospital
      2014   -   NCT02078141   France;
Allopurinol
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States;
Benazepril
   Xijing Hospital
      2005   Phase 4   NCT01917149   China;
Bone marrow mononuclear cells
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom;
Carvedilol
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States;
Coenzyme Q10
   University of Tehran
      2006   Phase 4   NCT02115581   Iran, Islamic Republic of;
Dobutamine
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States;
GRANOCYTE - 34 million IU (Lenograstim rHuG-CSF)
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom;
Granocyte Lenograstim
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom;
Granulocyte colony stimulating factor (GCSF)
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom;
HTEA
   Harbin Medical University
      2013   -   NCT02292043   China;
Honey
   mamdouh abdulmaksoud abdulrhman
      2015   Phase 2/Phase 3   NCT02987322   -
Infusion of autologous mononuclear bone marrow cells
   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
      2014   Phase 2   NCT02033278   Spain;
Metoprolol
   Xijing Hospital
      2005   Phase 4   NCT01917149   China;
Metoprolol succinate + doxazosin
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States;
Mono Nuclear Cell (MNC) transplantation
   Nasser Aghdami MD., PhD
      2013   Phase 1/Phase 2   NCT02256501   Iran, Islamic Republic of;
PL 12185/0002 & PL 12185/0005(WATER FOR INJECTION)
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom;
Umbilical cord mesenchymal stem cells
   Qingdao University
      2010   Phase 1/Phase 2   NCT01219452   China;
Valsartan
   Xijing Hospital
      2005   Phase 4   NCT01917149   China;